All News
Early Promise for Steroid-free Approach for Giant Cell Arteritis
A very small study presented at ACR18 looking at tocilizumab monotherapy in patients with a new diagnosis of giant cell arteritis has nevertheless given hope to the tantalising idea that some GCA patients might achieve drug-free remission without steroids, although broader data are requ
Read Article
Dr. Cush
ABSTRACT: 837
Efficacy of High-Dose Versus Standard-Dose Influenza Vaccine in Seropositive Rheumatoid Arthritis Patients —improved immune response to HD vs. SD for its on DMARDS +/- Biologics (except RTX), no increase Dz activity #ACR18 @Rheumnow
https://t.co/pviGwSNeVK
Suleman Bhana, MD DrBhana ( View Tweet)
Dr. Cush
ABSTRACT: L11
Etanercept & MTX As Monotherapy or in Combination in Patients with Psoriatic Arthritis: A Phase 3, Double-Blind, Randomized Controlled Study —Addition of MTX to ETN did not improve efficacy compared with ETN alone. #ACR18 @Rheumnow
https://t.co/6y8OTEVgPB
Suleman Bhana, MD DrBhana ( View Tweet)
Great to see our review article, 'The Impact of #Fibromyalgia in #Spondyloarthritis: From Classification Criteria to Outcome Measures' published in @FrontiersIn https://t.co/FjsseFlj0R @alessia_alunno #rheumatology #rheum #dontdelay #connecttoday
Simon Stones SimonRStones ( View Tweet)
#ACR18 For some background reading on your journal home, check out our #NovemberIssue.
Covering hand #osteoarthritis, the IL-23-IL-17 pathway in #bone, genetics and epigenetics in #systemicsclerosis and environmental factors in osteoarthritis.
https://t.co/VjcHwD0rIG https://t.co/9Gi3PfUWMz
Links:
NatRevRheumatol NatRevRheumatol ( View Tweet)
Terrific thread increasing your influence #ACR18
—Knowing what your personal&institutional priorities are is a key first step
—Understanding culture of different organizations and fields also critical as we work in interdisciplinary teams @LonaMody @LFerranteMD @TideswellUCSF https://t.co/NIPbHpzMBP
Una Makris UnaMakris ( View Tweet)
#ACR18 Rheum roundup highlights (1): 1) ANCA antibody positivity predict relapse in patients with GBM GN (not that we see a lot of these - mostly nephrologists); 2) SQ Tocilizumab did not improve skin scores, but improved lung function in #scleroderma after 48 weeks
Angelo Gaffo ALGaffoRheumMD ( View Tweet)
#FDAapproves new drug to treat influenza: https://t.co/3entnYURg4. https://t.co/qJeEcxJZvO
Links:
FDA Drug Information FDA_Drug_Info ( View Tweet)
.@LCalabreseDO discusses research that looked at comorbid vasculitis in the setting of primary immunodeficiency diseases. #ACR18 https://t.co/spbSadAMb0
Cleveland Clinic MD CleClinicMD ( View Tweet)
Eric Matteson have a great lecture on the history of cortisone, he really showed what a sensation this discovery was but showed aftermath of the side effects. He was kind enough to give an interview with rheuminations after so stay tuned! #ACR18 #cleclinicrheum @HealioRheum
Adam J Brown AdamJBrownMD ( View Tweet)
Eric M. Ruderman, MD: Addressing Safety Issues https://t.co/fm7HWriSIc via @mdmagazine
Eric Ruderman JointMD ( View Tweet)
This is a great summary of the lupus reproductive health guidelines. I’d add - manage & prevent disease activity with pregnancy-compatible medications. https://t.co/wWJgoNVFUL
Megan Clowse drbags71 ( View Tweet)
.@AlisonBays , it’s our abstract! https://t.co/fXOTbeuutS
Rheum Cat rheum_cat ( View Tweet)
@AngusWorthing @VickiShanmugam Nothing without the team. The real #ACR18 MVP's are the 50 ACR members that spent 2 days in Atlanta planning, the 400+ speakers and 3000+ abstract presenters for sharing their knowledge. Team ACR is honor to serve you. Thank you.
Donna Hoyne donna_hoyne ( View Tweet)
For anyone interested, here is the link for the PDF my slide deck for #ACR18 Tech Tools for Rheumatology talk: https://t.co/7oV7rTjpam
Suleman Bhana, MD DrBhana ( View Tweet)
Important workat the intersection of Vasculitis and PID. Ie when Immunologic galaxies collide!!!
@VasculitisFound @CleClinRheum #Acr18 https://t.co/L5tiNYQKEM
Leonard Calabrese LCalabreseDO ( View Tweet)
Check out this video on the SELECT COMPARE trial: upadacitinib vs adalimumab vs placebo in MTX IR patients https://t.co/Qkez4L8iA8 @ArthurRheum #ACR18
Arthur Lau ArthurRheum ( View Tweet)
In skin-predominant #dermatomyositis, #lenabasum, a #cannabinoid type 2 receptor agonist, reduced type 1 and 2 IFN levels in the skin. IL31 protein, assoc w pruritus, also decreased.
Abstract 2977. Dr.Werth #ACR18 @RheumNow https://t.co/2jmIak2B5B
Nicole Bitencourt NicoleBitencou5 ( View Tweet)
In myositis related #ILD, detection of pleural irregularities (PI) by #LungUltrasound correlated with findings on #HRCT Warwick score. Abstract 2979 Dr. Simone Barsotti. #ACR18 @RheumNow https://t.co/a4YPk4BGKV
Nicole Bitencourt NicoleBitencou5 ( View Tweet)
In #JDM, #calcification occurs in the mitochondria of affected muscles, leading to intracellular inflammation and mitochondrial DNA extrusion with Ab formation to mtDNA. #MitochondriaMatter in JDM! Abstract2981 Dr. Christian Lood #ACR18 @RheumNow https://t.co/BmBHPQoWDb
Nicole Bitencourt NicoleBitencou5 ( View Tweet)
